IMVT Financing Cash Flow
Immunovant Inc · Financing Cash Flow
IMVT Financing Cash Flow
Latest reported$612.94Mperiod ending
IMVT TTM Cash from Financing (-$59.61M → $612.94M)
TTM financing cash flow
High-resolution chart · PNG
IMVT financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 612,935,000 | |
| 595,756,000 | |
| 1,042,728,000 | |
| 480,589,000 | |
| 456,724,000 | |
| 454,492,000 | |
| 5,425,000 | |
| 472,805,000 | |
| 472,223,000 | |
| 472,427,000 | |
| 471,115,000 | |
| 71,902,000 | |
| 71,754,000 | |
| 70,885,000 | |
| 70,652,000 | |
| 21,000 | |
| 200,059,000 | |
| 200,129,000 | |
| 200,892,000 | |
| 201,338,000 | |
| 189,650,000 | |
| 383,112,000 | |
| 382,450,000 | |
| 382,112,969 | |
| 193,795,570 | |
| 117,236,905 | |
| -59,614,095 | |
| -45,228,064 | |
| -36,768,196 | |
| -148,698,564 |